Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RYTM | RHYTHM PHARMACEUTICALS, INC. | President and CEO, Director | $15.2M | -$820K | -5.13% | Feb 14, 2025 |
TRVI | Trevi Therapeutics, Inc. | Director | $1.03M | -$13.4K | -1.28% | Aug 27, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|